Ashkon Software



SNY Stock Report - Sanofi ADR

Sanofi ADR logo Sanofi is a multinational pharmaceutical company headquartered in Paris, France. The company specializes in the research, development, and manufacturing of pharmaceutical products and vaccines, with a focus on therapeutic areas such as oncology, immunology, rare diseases, and vaccines.

Sanofi has a portfolio of products that includes prescription medicines, over-the-counter products, and vaccines. Some of its well-known products include Lantus (insulin glargine), Dupixent (dupilumab) for atopic dermatitis, and Aubagio (teriflunomide) for multiple sclerosis.

Sanofi has a global presence, with operations in more than 170 countries. The company has a number of research and development facilities, including the Sanofi Genzyme R&D Center in Framingham, Massachusetts, and the Sanofi Pasteur R&D Center in Lyon, France.

In addition to its pharmaceutical business, Sanofi has a consumer healthcare division that produces over-the-counter products such as pain relievers and allergy medications. The company is also involved in the development of medical devices and has a partnership with Google to develop new healthcare technologies.

Sanofi is committed to sustainability and has set ambitious environmental and social goals. The company has pledged to reduce its greenhouse gas emissions by 55% by 2025 and to become carbon neutral by 2050. Sanofi is also committed to improving access to healthcare and has launched several initiatives to increase access to medicines and vaccines in developing countries.


Stock Sector: Drugs: Manufacturers - Major


Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer